Navigation Links
AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
Date:8/14/2008

eading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

National Cancer Centre Singapore

The National Cancer Centre Singapore (NCCS) is the premier cancer research and treatment facility in Singapore and in the region. It was established in 1997 and sees about 68 per cent of the public sector medical oncology cases and 74 per cent of radiation oncology cases. NCCS not only houses the most number of oncologists in Singapore but is also equipped with the largest number of equipment to provide the latest radiation oncology care in Singapore.

National University Hospital

The National University Hospital (NUH) is a specialist hospital that provides advanced, leading-edge medical care and services. Equipped with state-of-the-art facilities as well as dedicated and well-trained staff, NUH is a major referral centre that delivers tertiary care for a wide range of medical specialties including Cardiology, Gastroenterology & Hepatology, Obstetrics & Gynaecology, Oncology, Ophthalmology, Paediatrics and Orthopaedic Surgery. Backed by substantive expertise and experience, the NUH has been chosen by the Ministry of Health to develop two new national specialist centres to meet the growing need for heart and cancer treatments.

NUH, together with the National University of Singapore's Yong Loo Lin School of Medicine and Faculty of Dentistry, are under the common governance of the National University Health System (NUHS). Formed in January 2008, NUHS provides a unified platform for these three entities to create greater synergies to achieve its tripartite mission of excellence in clinical care, translational clinical research and education. With combined capabilities and facilities (from the teaching hospital and m
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
2. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
3. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
4. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
5. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
8. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
9. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
10. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
11. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  The efficacy of continuous ... in a recently published study 1 of ultraviolet ... research team, including Curtis Donskey , M.D.  The ... for the same length of time from the same ... unit.  The results showed surprisingly low pathogen kill rates ...
(Date:3/31/2015)... According to a new ... Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, ... Centrifuge) - Global Forecast to 2019", published by ... Market is expected to reach $48.84 Billion by ... 2019. Browse   9 ...
(Date:3/31/2015)... Calif. , March 31, 2015  Frequentz Inc., ... has released a white paper to help the pharmaceutical ... 2013 Drug Supply Chain Security Act (DSCSA). The white ... stages of the GS1 EPCIS Standard(s) and ... outlook on the product tracing requirements that need to ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3
... Causing Mitochondrial Disease More Common Than Previously,Believed, ... (UMDF) today announced landmark research finding that,one in ... could potentially cause a,mitochondrial disease in them or ... fatal disease, and mitochondrial disorders are at,the core ...
... Sanofi-aventis,(EURONEXT: SAN and NYSE: SNY) announced today ... priority review status for its New Drug,Application (NDA) ... July 31, 2008., The priority review is ... new drug product, if approved, has the potential ...
Cached Medicine Technology:New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 2New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 3Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 2Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 3
(Date:3/31/2015)... 2015 Healthpointe’s team of hip ... of their clinics. Specialties include hip dislocations, fractures, bursitis, ... athletes with hip injuries, Healthpointe has a renowned team ... the symptoms and underlying causes of the hip pain. ... prevent future damage, while taking into consideration the patient’s ...
(Date:3/31/2015)... 2015 Former 49ers linebacker Chris Borland turned ... first year of a promising NFL career. In a March ... Senior Writer Will Leitch explores the curious case of ... about the decision making process that Borland and other football ... over a large paycheck, and what impact, if any, he ...
(Date:3/31/2015)... March 31, 2015 Array Health ... technology, has announced that Lance Hood, Senior Director of ... Private Exchange Forum on April 1, 2015. The session, ... Benaissance, will address how employers can streamline and simplify ... , WHAT: “ Optimizing Employee and Employer Needs in ...
(Date:3/31/2015)... March 31, 2015 As the scientific ... Energy Balance Network (GEBN) is poised to make ... public health. GEBN is a network of scientists ... Africa, Asia and Oceania who have banded together to ... by the body (energy balance) and apply this understanding ...
(Date:3/31/2015)... York (PRWEB) March 31, 2015 Lipitor ... individuals who allegedly developed new-onset Type 2 diabetes due ... move forward in the federal multidistrict litigation now underway ... to an Order issued on March 26th, jury selection ... November 4, 2015. (In re Lipitor (Atorvastatin) Litigation, MDL ...
Breaking Medicine News(10 mins):Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 3Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 3
... July 31 Nevique(TM), a newly,founded skin care ... revolutionary new Omega 3 skin care technology at ... TX on August 5-8, 2008. The,Nevique(TM) skin care ... balm formulas: 1) Ultra Moisturizer, 2) Daily Conditioner, ...
... Cyberonics, Inc. (Nasdaq:,CYBX) today announced that the company will report ... its fiscal year ending April 24,2009 on Thursday, August 21, ... call to discuss those results on the same day at ... Conference Call Instructions, To listen to the conference call ...
... cells to treat fatal disease, researchers say , , THURSDAY, July ... patients with Lou Gehrig,s disease into motor neurons that are ... number of these neurons can now be created and studied ... better understanding of the disease and, one day, lead to ...
... , ... Orlando, FL (Vocus) July 31, 2008 -- ... in its "Hype Cycle for Healthcare Payers, 2008" report. Connextions, a ... retain and manage individual and small group members. , ...
... Announced, ROCHESTER, Mich., July 31 Oakland,University,s ... Robert,Folberg, M.D., as the founding dean of the ... in 2010 with a charter class of,50 students. ... of the,school -- Oakland University William Beaumont School ...
... president & chief operating officer, Medco Health Solutions, Inc.,(NYSE: ... Capital Markets 2008 Focus on,Healthcare Conference in New York ... the Millennium Broadway Hotel will begin at 9:00,a.m. ET. ... to,attend., The presentation may be heard live via ...
Cached Medicine News:Health News:Nevique Skin Care Company Introducing the Revolutionary New Omega 3 Skin Care Technology 2Health News:Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 3Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 2Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 3Health News:OU, Beaumont Name Dean of New Medical School 2Health News:OU, Beaumont Name Dean of New Medical School 3Health News:Medco to Present at the BMO Capital Markets 2008 Focus on Healthcare Conference 2
... designed to optimize the accuracy and precision ... products is widely recognized by customers throughout ... extended over the years and now covers ... tips including filter tips, certified pure tips, ...
... Processor is a primary component of an ... processing, sampling, and slide preparation all ... MonoPrep LBP Processor produces high-quality sample slides ... range of cytology specimen types. It processes ...
... innovative, quick and easy automated refill ... less space on your laboratory bench ... amazingly easy-to-use, one-hand system, you only ... range of Diamond Tips. All sizes ...
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Medicine Products: